News

Lin Health Partners with Mayo Clinic to Enhance Pain Management

Lin Health Partners with Mayo Clinic to Enhance Pain Management

Lin Health Partners with Mayo Clinic to Enhance Pain Management

Retraining the brain's neural circuitry through a behavioral health approach empowers individuals living with chronic pain to avoid costly and risky overtreatment.

Collaboration Objectives

Lin Health, a digital platform dedicated to helping individuals reclaim their lives from chronic pain, has joined forces with Mayo Clinic to enhance transition support for patients concluding the Fibromyalgia Treatment Program. Initially focusing on Mayo Clinic's Rochester campus, this collaboration is designed to evolve in order to assist primary care patients in a new region, establishing an at-home, high-touch digital intervention that provides ongoing, real-time support for those experiencing chronic pain.

The Burden of Chronic Pain

Chronic pain represents a significant challenge within the healthcare system, affecting a substantial portion of the population. Reports suggest that over one in five adults experience chronic pain, which translates into an astonishing economic impact, with costs soaring as high as $635 billion annually. This complex issue lacks a universal solution and exacerbates numerous critical healthcare challenges, including the opioid crisis and the rising rates of associated mental health and addiction problems.

New Insights into Chronic Pain

Recognizing the multifaceted nature of pain, the World Health Organization’s ICD-11 introduced the classification of chronic primary pain in 2022, acknowledging pain as a primary disorder influenced by various bio-psycho-social factors. This paradigm shift opens up opportunities to refine treatment strategies focusing more on the nervous system, with emerging studies showing that innovative therapies can lead to remarkable improvements in patients' experiences with chronic pain.

Lin Health’s Approach

Lin Health's behavioral health approach taps into current research and clinical evidence to provide personalized and effective chronic pain management. Their model involves collaborating with health systems and clinics under the Collaborative Care Model, utilizing a human-led, AI-driven platform to synchronize care efforts and address gaps in chronic pain treatment.

Patient-Centric Vision

Yehuda Kogan, CEO and Co-Founder of Lin Health, underscores the importance of improving the patient-provider relationship by integrating advanced technology within the healthcare framework. His vision is to empower care providers to offer genuine hope and validation to patients, presenting them with first-line, non-invasive treatment alternatives for chronic pain.

About Lin Health

Lin Health is on a mission to help individuals reclaim their lives from chronic pain through personalized, tech-enabled care. Established in 2021 and based in Denver, the company leverages cutting-edge research to address diverse pain conditions like migraines and back pain. They collaborate with various healthcare entities to deliver affordable and accessible non-pharmacological solutions targeting prevalent neurological pain issues.

Growth and Impact

The platform has achieved a significant milestone, with plans to facilitate over 1 million care interventions by the end of 2024. Lin Health currently serves around 27 million patients under various health plans, including prominent providers such as Aetna and UnitedHealthcare.

Funding Initiatives

With total funding reaching $15.4 million, Lin Health's recent investment round yielded $5.2 million, driven by key industry partners like Mayo Clinic and several health-focused venture capital firms.

Frequently Asked Questions

What is the focus of Lin Health's collaboration with Mayo Clinic?

The collaboration aims to improve care transition support for chronic pain patients completing treatment programs, enhancing their ongoing care experience.

Why is chronic pain a significant issue in healthcare?

Chronic pain affects millions, leading to substantial healthcare costs and contributing to other pressing issues like the opioid crisis and mental health challenges.

How does Lin Health’s approach differ from traditional pain management?

Lin Health emphasizes personalized, tech-driven solutions that target the nervous system and employ behavioral health strategies, moving away from standard pharmacological treatments.

What innovative treatments is Lin Health implementing?

Lin Health is incorporating evidence-based techniques focused on neuroplasticity, offering scalable, individualized interventions to manage chronic pain effectively.

What is the company's future outlook?

Lin Health is positioned for growth, aspiring to reach more patients and improve outcomes with its AI-driven platform by supporting over a million care interventions by 2024.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 303

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 421

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 344

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
News Articles